VALISONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Valisone, and when can generic versions of Valisone launch?
Valisone is a drug marketed by Schering and is included in three NDAs.
The generic ingredient in VALISONE is betamethasone valerate. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Valisone
A generic version of VALISONE was approved as betamethasone valerate by FOUGERA on August 31st, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VALISONE?
- What are the global sales for VALISONE?
- What is Average Wholesale Price for VALISONE?
Summary for VALISONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 7,031 |
| DailyMed Link: | VALISONE at DailyMed |
US Patents and Regulatory Information for VALISONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | VALISONE | betamethasone valerate | CREAM;TOPICAL | 016322-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Schering | VALISONE | betamethasone valerate | OINTMENT;TOPICAL | 016740-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Schering | VALISONE | betamethasone valerate | CREAM;TOPICAL | 016322-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Schering | VALISONE | betamethasone valerate | LOTION;TOPICAL | 016932-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
